Patents by Inventor DANIEL SCOTT GIRARD

DANIEL SCOTT GIRARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND METHODS TARGETING EPIREGULIN
    Publication number: 20250101091
    Abstract: The present invention relates to epiregulin antibodies, compositions comprising the same, and methods of making and/or using the antibodies and/or compositions thereof for chronic pain disorders such as chronic osteoarthritis pain, or chronic diabetic peripheral neuropathy pain, or chronic low back pain.
    Type: Application
    Filed: June 26, 2024
    Publication date: March 27, 2025
    Inventors: Catherine Brautigam BEIDLER, Jeffrey Streetman BOYLES, Daniel Scott GIRARD, Shannon Marie HARLAN, Michael Parvin JOHNSON
  • AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENTS
    Publication number: 20250064958
    Abstract: Provided herein are APP RNAi agents and compositions comprising an APP RNAi agent. Also provided herein are methods of using the APP RNAi agents or compositions comprising an APP RNAi agent in reducing APP expression and/or treating APP associated neurological diseases.
    Type: Application
    Filed: August 16, 2024
    Publication date: February 27, 2025
    Inventors: Riazul ALAM, Jee-Wei Emily CHEN, Carrie Hughes CROY, David Albert DRIVER, Sarah Katharina FRITSCHI, Daniel Scott GIRARD, Isabel C. GONZALEZ VALCARCEL, Ruben Martin MARTINEZ, Rebecca Ruth MILES, Hatice Gulcin OZER, Douglas Raymond PERKINS, Jibo WANG
  • COMPOUNDS FOR THE DELIVERY OF GRANULIN ACROSS THE BLOOD BRAIN BARRIER
    Publication number: 20250000992
    Abstract: Compounds for the delivery of progranulin, a progranulin fragment, and/or at least one granulin protein subunit across the blood brain barrier. Compounds for the delivery of progranulin, a progranulin fragment, and/or at least one granulin protein subunit across the blood brain barrier, the compounds including a progranulin domain, a TfR1 binding domain, and optionally an albumin binding domain. Compounds for the delivery of wildtype or unmodified progranulin across the blood brain barrier.
    Type: Application
    Filed: June 18, 2024
    Publication date: January 2, 2025
    Inventors: Alberto ALVARADO, Forest H. ANDREWS, David Albert DRIVER, Ross Edward FELLOWS, Karen Jean FRONING, Daniel Scott GIRARD, Petra VERDINO, Yaming WANG
  • COMPOUNDS AND METHODS TARGETING EPIREGULIN
    Publication number: 20220372124
    Abstract: The present invention relates to epiregulin antibodies, compositions comprising the same, and methods of making and/or using the antibodies and/or compositions thereof for chronic pain disorders such as chronic osteoarthritis pain, or chronic diabetic peripheral neuropathy pain, or chronic low back pain.
    Type: Application
    Filed: May 19, 2022
    Publication date: November 24, 2022
    Inventors: Catherine Brautigam Beidler, Jeffrey Streetman Boyles, Daniel Scott Girard, Shannon Marie Harlan, Michael Parvin Johnson
  • Anti-TrkA antibody
    Patent number: 10618974
    Abstract: Antibodies to tropomysin receptor kinase (TrkA), compositions including such antibodies, and methods of using such antibodies for the treatment of pain including post-surgical pain, rheumatoid arthritis pain, neuropathic pain and osteoarthritis pain.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: April 14, 2020
    Assignee: Eli Lilly and Company
    Inventors: Catherine Brautigam Beidler, Daniel Scott Girard, Chetankumar Natvarlal Patel
  • ANTI-TRKA ANTIBODY
    Publication number: 20190263932
    Abstract: Antibodies to tropomysin receptor kinase (TrkA), compositions including such antibodies, and methods of using such antibodies for the treatment of pain including post-surgical pain, rheumatoid arthritis pain, neuropathic pain and osteoarthritis pain.
    Type: Application
    Filed: February 21, 2019
    Publication date: August 29, 2019
    Inventors: Catherine Brautigam Beidler, Daniel Scott Girard, Chetankumar Natvarlal Patel
  • ANTIBODIES THAT BIND IL-23
    Publication number: 20170275356
    Abstract: The present invention provides an antibody that binds to the p19 subunit of human IL-23 and is characterized as having high affinity, selective, and neutralizing properties. The antibody is useful in the treatment or prevention of an autoimmune or inflammatory condition selected from the group consisting of consisting of multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, ankylosing spondylitis, graft-versus-host disease, lupus and metabolic syndrome. The antibody is also useful in the treatment of cancer.
    Type: Application
    Filed: June 1, 2017
    Publication date: September 28, 2017
    Inventors: Catherine Brautigam Beidler, Stuart Willis Bright, Daniel Scott Girard, Kristine Kay Kikly
  • Nucleic acids encoding antibodies that bind IL-23
    Patent number: 9688753
    Abstract: The present invention provides an antibody that binds to the p19 subunit of human IL-23 and is characterized as having high affinity, selective, and neutralizing properties. The antibody is useful in the treatment or prevention of an autoimmune or inflammatory condition selected from the group consisting of consisting of multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, ankylosing spondylitis, graft-versus-host disease, lupus and metabolic syndrome. The antibody is also useful in the treatment of cancer.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: June 27, 2017
    Assignee: Eli Lilly and Company
    Inventors: Catherine Brautigam Beidler, Stuart Willis Bright, Daniel Scott Girard, Kristine Kay Kikly
  • ANTIBODIES THAT BIND IL-23
    Publication number: 20150232552
    Abstract: The present invention provides an antibody that binds to the p19 subunit of human IL-23 and is characterized as having high affinity, selective, and neutralizing properties. The antibody is useful in the treatment or prevention of an autoimmune or inflammatory condition selected from the group consisting of consisting of multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, ankylosing spondylitis, graft-versus-host disease, lupus and metabolic syndrome. The antibody is also useful in the treatment of cancer.
    Type: Application
    Filed: May 1, 2015
    Publication date: August 20, 2015
    Inventors: Catherine Brautigam Beidler, Stuart Willis Bright, Daniel Scott Girard, Kristine Kay Kikly
  • Antibodies that bind to IL-23
    Patent number: 9023358
    Abstract: The present invention provides an antibody that binds to the p19 subunit of human IL-23 and is characterized as having high affinity, selective, and neutralizing properties. The antibody is useful in the treatment or prevention of an autoimmune or inflammatory condition selected from the group consisting of consisting of multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, ankylosing spondylitis, graft-versus-host disease, lupus and metabolic syndrome. The antibody is also useful in the treatment of cancer.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: May 5, 2015
    Assignee: Eli Lilly and Company
    Inventors: Catherine Brautigam Beidler, Stuart Willis Bright, Daniel Scott Girard, Kristine Kay Kikly
  • ANTIBODIES THAT BIND TO IL-23
    Publication number: 20140255422
    Abstract: The present invention provides an antibody that binds to the p19 subunit of human IL-23 and is characterized as having high affinity, selective, and neutralizing properties. The antibody is useful in the treatment or prevention of an autoimmune or inflammatory condition selected from the group consisting of consisting of multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel diseases, ankylosing spondylitis, graft-versus-host disease, lupus and metabolic syndrome. The antibody is also useful in the treatment of cancer.
    Type: Application
    Filed: March 4, 2014
    Publication date: September 11, 2014
    Applicant: Eli Lilly and Company
    Inventors: CATHERINE BRAUTIGAM BEIDLER, STUART WILLIS BRIGHT, DANIEL SCOTT GIRARD, KRISTINE KAY KIKLY